Latest Articles

Publication Date
Standardized measurement of the piriformis muscle and the proximal portion of the sacral nerve roots using transvaginal ultrasound.

To identify the sonomorphological appearance and to measure the thickness of the piriformis muscle (PM) and the proximal portion of the sacral nerve roots S1-S3 in healthy premenopausal women.

Published: Jan. 21, 2025, midnight
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data.

Dietary factors have recently been recognized as potentially influential in the pathogenesis of endometriosis (EM), yet studies on the causal relationship between dietary preferences and EM are limited. The present …

Published: Jan. 21, 2025, midnight
Social media activism and women's health: Endometriosis awareness and support.

While endometriosis is estimated to affect 1 in 10 women globally, awareness of the disease as well as research and funding to fight the disease remains lacking as compared with …

Published: Jan. 21, 2025, midnight
Neutrophils initiate pro-inflammatory immune responses in early endometriosis lesion development.

Endometriosis is a chronic gynecological disease that affects 1 in 10 reproductive-aged women. Most studies investigate established disease; however, the initiation and early events in endometriotic lesion development remain poorly …

Published: Jan. 21, 2025, midnight
Ovarian Endometrioma Disrupts Oocyte-Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects.

Ovarian endometrioma (OEM), a particularly severe form of endometriosis, is an oestrogen-dependent condition often associated with pain and infertility. The mechanisms by which OEM impairs fertility, particularly through its direct …

Published: Jan. 21, 2025, midnight
Orexo converts vipoglanstat royalties into Gesynta stake - The Pharma Letter

Orexo converts vipoglanstat royalties into Gesynta stake The Pharma Letter

Published: Jan. 20, 2025, 4:47 p.m.
Lab tech firm BioGrad opening £25m women's health centre - Business Live

Lab tech firm BioGrad opening £25m women's health centre Business Live

Published: Jan. 20, 2025, 2 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted

Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted

Published: Jan. 20, 2025, 8:21 a.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma

GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma

Published: Jan. 20, 2025, 7:14 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!